PMID- 29942404
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20200929
IS  - 1869-3474 (Print)
IS  - 1869-3482 (Electronic)
IS  - 1869-3474 (Linking)
VI  - 52
IP  - 3
DP  - 2018 Jun
TI  - Incidental Detection of Parathyroid Adenoma on Somatostatin Receptor PET/CT and 
      Incremental Role of (18)F-Fluorocholine PET/CT in MEN1 Syndrome.
PG  - 238-242
LID - 10.1007/s13139-018-0520-2 [doi]
AB  - Multiple endocrine neoplasia type 1 (MEN1) syndrome is characterized by combined 
      occurrence of tumors of endocrine glands including the parathyroid, the 
      pancreatic islet cells, and the anterior pituitary gland. Parathyroid involvement 
      is the most common manifestation and usually the first clinical involvement in 
      MEN1 syndrome, followed by gastroentero-pancreatic neuroendocrine tumors (NETs). 
      Here we present a case where the patient initially presented with metastatic 
      gastric NET and a single parathyroid adenoma was detected incidentally on 
      (68)Ga-DOTANOC PET/CT done as part of post (177)Lu-DOTATATE therapy (PRRT) 
      follow-up. Further (18)F-fluorocholine PET/CT showed four adenomas for which the 
      patient subsequently underwent subtotal parathyroidectomy.
FAU - Arora, Saurabh
AU  - Arora S
AD  - 1Department of Nuclear Medicine, All India Institute of Medical Sciences, New 
      Delhi, 110029 India. ISNI: 0000 0004 1767 6103. GRID: grid.413618.9
FAU - Damle, Nishikant Avinash
AU  - Damle NA
AD  - 1Department of Nuclear Medicine, All India Institute of Medical Sciences, New 
      Delhi, 110029 India. ISNI: 0000 0004 1767 6103. GRID: grid.413618.9
FAU - Passah, Averilicia
AU  - Passah A
AD  - 1Department of Nuclear Medicine, All India Institute of Medical Sciences, New 
      Delhi, 110029 India. ISNI: 0000 0004 1767 6103. GRID: grid.413618.9
FAU - Yadav, Madhav Prasad
AU  - Yadav MP
AD  - 1Department of Nuclear Medicine, All India Institute of Medical Sciences, New 
      Delhi, 110029 India. ISNI: 0000 0004 1767 6103. GRID: grid.413618.9
FAU - Ballal, Sanjana
AU  - Ballal S
AD  - 1Department of Nuclear Medicine, All India Institute of Medical Sciences, New 
      Delhi, 110029 India. ISNI: 0000 0004 1767 6103. GRID: grid.413618.9
FAU - Aggarwal, Vivek
AU  - Aggarwal V
AD  - Department of Endocrine Surgery, Maharaja Agrasen Hospital, New Delhi, India.
FAU - Gupta, Yashdeep
AU  - Gupta Y
AD  - 3Department of Endocrine, All India Institute of Medical Sciences, New Delhi, 
      110029 India. ISNI: 0000 0004 1767 6103. GRID: grid.413618.9
FAU - Kumar, Praveen
AU  - Kumar P
AD  - 1Department of Nuclear Medicine, All India Institute of Medical Sciences, New 
      Delhi, 110029 India. ISNI: 0000 0004 1767 6103. GRID: grid.413618.9
FAU - Tripathi, Madhavi
AU  - Tripathi M
AD  - 1Department of Nuclear Medicine, All India Institute of Medical Sciences, New 
      Delhi, 110029 India. ISNI: 0000 0004 1767 6103. GRID: grid.413618.9
FAU - Bal, Chandrasekhar
AU  - Bal C
AD  - 1Department of Nuclear Medicine, All India Institute of Medical Sciences, New 
      Delhi, 110029 India. ISNI: 0000 0004 1767 6103. GRID: grid.413618.9
LA  - eng
PT  - Case Reports
DEP - 20180502
PL  - Germany
TA  - Nucl Med Mol Imaging
JT  - Nuclear medicine and molecular imaging
JID - 101530478
PMC - PMC5995772
OTO - NOTNLM
OT  - 177Lu-DOTATATE therapy
OT  - 18F-Fluorocholine PET/CT
OT  - Gastrinoma
OT  - Hyperparathyroidism
OT  - MEN1
COIS- Compliance with Ethical StandardsSaurabh Arora, Nishikant Avinash Damle, 
      Averilicia Passah, Madhav Prasad Yadav, Sanjana Ballal, Vivek Aggarwal, Yashdeep 
      Gupta, Praveen Kumar, Madhavi Tripathi, and Chandrasekhar Bal declare that they 
      have no conflict of interest.All procedures performed in studies involving human 
      participants were in accordance with the ethical standards of the institutional 
      and/or national research committee and with the 1964 Helsinki declaration and its 
      later amendments or comparable ethical standards.Informed consent was obtained 
      from all individual participants included in the study.
EDAT- 2018/06/27 06:00
MHDA- 2018/06/27 06:01
PMCR- 2019/06/01
CRDT- 2018/06/27 06:00
PHST- 2018/01/29 00:00 [received]
PHST- 2018/03/25 00:00 [revised]
PHST- 2018/04/05 00:00 [accepted]
PHST- 2018/06/27 06:00 [entrez]
PHST- 2018/06/27 06:00 [pubmed]
PHST- 2018/06/27 06:01 [medline]
PHST- 2019/06/01 00:00 [pmc-release]
AID - 520 [pii]
AID - 10.1007/s13139-018-0520-2 [doi]
PST - ppublish
SO  - Nucl Med Mol Imaging. 2018 Jun;52(3):238-242. doi: 10.1007/s13139-018-0520-2. 
      Epub 2018 May 2.